Neurological disorders refer to conditions that affect the nervous system, which includes the brain, spinal cord, and nerves. They can result from damage to the central nervous system, including the brain and spinal cord, or from problems with the peripheral nervous system, which includes the nerves that connect the brain and spinal cord to the rest of the body.
Examples of neurological diseases include Alzheimer's disease, Parkinson's disease, multiple sclerosis, epilepsy, migraine, stroke, and spinal cord injuries.
These conditions can cause a wide range of symptoms, including problems with movement, sensation, memory, behavior, and overall functioning. They are typically difficult to study, as direct treatments and observations have physical or physiological limitations.
There are several research and development experimental models for neurological disorders, including:
Cell culture models: This involves growing cells in a laboratory setting to study the effects of drugs, toxins, and genetic changes on cell function and survival.
Animal models: This involves using animals, such as mice and rats, to study the development and progression of neurological diseases. Researchers can induce the disease in animals through genetic modification or through the administration of drugs or toxins.
Human induced pluripotent stem cell (iPSC) models: This involves reprogramming human cells to a stem cell-like state and then differentiating them into specific cell types, such as neurons or glia. These models allow for the study of the effects of genetic mutations and drug treatments on human cells.
In vitro slice models: This involves preparing thin slices of brain tissue from animals or humans and maintaining them in a dish for observation and experimentation.
Organoids: This involves growing three-dimensional structures from stem cells that mimic the organization and function of specific tissues or organs.
These experimental models provide a valuable tool for researchers to study the mechanisms of neurological diseases and test potential treatments. The results from these models can then be translated to human clinical trials to determine the safety and efficacy of treatments for neurological diseases.
Please answer the fields below to be contacted by our team of scientists
Perform a feasibility study by looking for existing samples already in collections & ready to be transferred
Set up a clinical biological collection and preparing contracts with sources
Assist the material transfer from the source to the lab, including treatments, QA or shipping, as needed